Xarenel

Quick links to important sections

Xarenel

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Xarenel

Quick Facts

Property Description
Active ingredient Colecalciferol (Vitamin D3)
Form Oral (capsules, tablets, liquid solution)
Pharmacological class Vitamin D analogue, Dietary supplement
Common use Supports mineral balance and bone health
Origin Derived substance (lipid-soluble)

Xarenel: Definition, Composition, and Pharmacological Class

Xarenel is a pharmaceutical preparation classified as a Dietary Supplement and a Vitamin D analogue, containing Colecalciferol as its single active ingredient. This compound is chemically recognized as Cholecalciferol or Vitamin D3 and is classified as a secosteroid that functions as a prohormone, meaning it is the biologically inactive precursor form of the vitamin that the body must transform to utilize. This Colecalciferol form is identical to the vitamin produced via endogenous synthesis in the skin. The distinction from the analogue Ergocalciferol (Vitamin D2) is clinically recognized, as Colecalciferol is often preferred for its efficacy in correcting deficiency and providing a sustained increase in circulating vitamin levels.


What Type of Preparation and General Purpose is Colecalciferol?

Xarenel is provided in various oral dosage forms including capsules, tablets, and oral liquid solutions (drops). Since Colecalciferol is a lipid-soluble substance, it is typically formulated with a lipid base vehicle to ensure effective absorption within the gastrointestinal tract. The Colecalciferol in this medication is a derived substance that complements the body’s own production. This supplemental source allows users to reliably obtain a controlled amount of the precursor vitamin.

Once converted into the hormonally active form (Calcitriol), Colecalciferol significantly enhances the intestinal absorption of calcium and phosphate from the diet. This physiological action is indispensable for maintaining proper calcium homeostasis and providing the materials necessary for robust bone mineralization and the structural integrity of the skeleton.

Regulatory References

  1. Cholecalciferol - StatPearls - NIH
  2. Cholecalciferol (Vitamin D3): MedlinePlus Drug Information

What side effects are possible with Xarenel?

Possible Side Effects and Safety Information

The official safety profile for Xarenel (Colecalciferol) is primarily defined by the potential for an excessive buildup of calcium, which is known as Hypercalcaemia (high calcium in the blood) and Hypercalciuria (high calcium in the urine). Adverse reactions are classified by frequency according to regulatory documentation.


Official Adverse Reaction Frequencies

Classification Adverse Reaction System-Organ Class
Uncommon Hypercalcaemia, Hypercalciuria Metabolism and Nutrition
Rare Pruritus, Rash, Urticaria Skin and Subcutaneous Tissue
Not Known Nausea, Vomiting, Constipation, Headache, Fatigue Gastrointestinal, Nervous System

Serious Adverse Reactions and Safety Restrictions

Serious adverse reactions are typically associated with prolonged high-dose exposure, resulting in Hypervitaminosis D. The most significant documented risk involves the Renal and Urinary system; this includes Nephrocalcinosis and Nephrolithiasis (kidney stone formation). These effects are a consequence of sustained Hypercalciuria.

Regulatory documents include specific restrictions for use. Xarenel should not be used in individuals with pre-existing conditions such as Hypercalcaemia, Hypercalciuria, or confirmed Hypervitaminosis D. Caution is also advised in patients with renal impairment or conditions like Sarcoidosis, due to an increased risk of toxicity and altered calcium handling. Additionally, Hypercalcaemia can potentiate the effects of co-administered Digitalis Glycosides.

Overdose and Emergency Response

Colecalciferol (Xarenel) overdose is officially documented as hypervitaminosis D, with the central finding being hypercalcaemia (abnormally high levels of calcium in the blood). Documented manifestations of overdose include systemic symptoms such as fatigue, generalized weakness, headache, increased thirst (polydipsia), and increased urination (polyuria), alongside gastrointestinal disturbances like nausea, vomiting, and loss of appetite (anorexia).

The regulatory profile highlights the potential for irreversible organ damage, specifically renal failure (including nephrocalcinosis and kidney stones) and calcification of soft tissues. Severe toxicity can escalate to cardiac arrhythmias and severe central nervous system effects, including profound mental disturbances and, in extreme cases, coma.

Immediate medical attention must be sought if any symptoms of toxicity or overdose are suspected. Regulators mandate the immediate cessation of the Colecalciferol dose as the primary step. Urgent help, including contacting emergency services, is required if the affected person collapses, experiences a seizure, or is unresponsive.

Management is described as symptomatic and supportive; no specific antidote for Colecalciferol is known. Procedures include intravenous rehydration and the use of specialized agents like glucocorticoids or bisphosphonates to normalize calcium levels. Close monitoring of serum calcium, renal function, and cardiac status is required. Official labeling also notes that overdose must be avoided during pregnancy due to the risk of fetal harm.

Therapeutic Uses of Xarenel

What Xarenel Treats: Main Uses and Benefits

Xarenel (Colecalciferol) is commonly used to address conditions and symptoms stemming from an underlying Vitamin D deficiency or to provide targeted support for mineral balance in the body. Its primary therapeutic goal is applied in addressing symptomatic discomfort related to skeletal health.

The main therapeutic uses are directly related to bone and mineral health, as Colecalciferol is essential for the body's proper use of calcium and phosphate.

The medication is generally applied across conditions like osteoporosis, osteomalacia, and rickets, and is relevant for managing chronic bone pain and generalized muscle weakness (myopathy) linked to prolonged deficiency. Xarenel is commonly used as a long-term measure to support skeletal structure and assist in easing the overall burden of chronic bone-related symptoms.

Therapeutic Benefit

This preparation is applicable for the management of skeletal fragility and supports the body's ability to promote stronger, denser bone structure. This provides a supportive therapeutic benefit that helps improve day-to-day comfort during symptomatic periods, assisting with maintaining functional stability.


Quick Fact: Relief for Musculoskeletal Symptoms
Symptom Cluster Chronic Bone Pain & Muscle Weakness
Primary Benefit Supports improved comfort and functional stability
Context of Use Management of systemic deficiency states

Regulatory References

  1. NIH MedlinePlus overview on Vitamin D

Eligibility and Restrictions for Use

Who can and cannot use Xarenel?

The eligibility for Xarenel (Colecalciferol) is determined by regulatory agencies and focuses on avoiding conditions that lead to excessive Vitamin D or calcium levels. Use is generally indicated for adults and adolescents over 12 years for deficiency treatment or prevention.


Contraindications (Who Must Not Use)

Xarenel is strictly contraindicated in patients with a history of:

  • Hypercalcaemia (high blood calcium levels) or Hypercalciuria (high urine calcium levels).
  • Hypervitaminosis D (existing high Vitamin D levels).
  • Severe renal impairment (severe kidney dysfunction).
  • Kidney stones (nephrolithiasis) in the presence of hypercalcaemia.

Restrictions and Special Populations

Population Regulatory Status
Children Under 12 Use is often not recommended for standard adult/adolescent formulations.
Pregnancy Restricted use; not recommended unless clinically required to treat a documented deficiency.
Lactation Permitted use, but the dose must be considered for the breastfed infant.
Mild Renal Impairment Conditional use; requires close monitoring of calcium and phosphate levels.
Sarcoidosis Conditional use; requires close monitoring of calcium levels due to altered metabolism.

Eligibility rules are set to prevent toxicity and ensure the medicine is appropriate for the individual's underlying health status.

What should I know about interactions with other medicines?

Xarenel is a preparation of Cholecalciferol (Vitamin D3), and its potential interactions are based on the effects of this substance, particularly concerning calcium levels and medication absorption or metabolism. Interactions can be clinically significant, especially with high-dose regimens.

Interacting Medication Categories and Specific Medicines

Interactions that may reduce Xarenel's effectiveness or absorption include:

  • Certain Seizure Medications: Medicines such as phenytoin, carbamazepine, or phenobarbital may cause Vitamin D to be broken down more quickly in the body, potentially requiring a higher Cholecalciferol dose.
  • Bile Acid Sequestrants: Cholesterol-lowering medicines like cholestyramine can bind to Vitamin D in the intestine, reducing the amount absorbed by the body. A spacing requirement of several hours between these medicines and Xarenel may be necessary.
  • Weight Loss Drugs: Orlistat may decrease the absorption of Vitamin D.

Interactions that may increase the risk of hypercalcemia (high calcium levels) include:

  • Thiazide Diuretics: These "water pills," such as hydrochlorothiazide, decrease the excretion of calcium by the kidneys, increasing the risk of excessively high calcium levels when taken with high-dose Vitamin D.
  • Digitalis (Digoxin): The risk of serious heart rhythm issues is increased if high blood calcium levels occur while taking heart medicines like digoxin. Close monitoring is essential.

Other Relevant Interactions

  • Steroid Medicines: Medications like prednisone may reduce the body's ability to absorb calcium, which can affect the overall effectiveness of Vitamin D therapy.
  • Aluminum-Containing Antacids: Long-term use of antacids containing aluminum may lead to increased aluminum absorption, which can be problematic, especially for individuals with kidney issues.

Patients should avoid taking other high-dose Vitamin D or calcium supplements without medical supervision to prevent hypercalcemia.

Mechanism of Action

How Xarenel Works

Xarenel's mechanism is predicated on its identity as a prohormone, requiring two metabolic steps to become the active hormonal ligand, Calcitriol, which subsequently regulates mineral homeostasis across multiple organ systems.

Activation and Nuclear Receptor Agonism

The mechanism initiates with the conversion of Colecalciferol to Calcitriol, a process relying on specific enzymes in the liver and kidneys. The active Calcitriol then acts as an agonist for the Vitamin D Receptor (VDR), a nuclear receptor that controls gene transcription for transport proteins. This genomic action results in a sustained, regulatory effect on targeted pathways.

️ Transcriptional Control of Systemic Mineral Balance

VDR activation leads to the upregulation of mineral transport proteins in the intestines and kidneys, increasing the cellular capacity for absorbing calcium and phosphate from the diet while simultaneously reducing their loss through excretion. Furthermore, the active ligand suppresses the synthesis of Parathyroid Hormone (PTH) in an endocrine feedback loop. These coordinated actions provide the necessary mineral building blocks and hormonal environment required for the maintenance of systemic mineral balance.

Mechanism Dependence and Limitations

The resultant physiological effect is dependent on the enzymatic activity of the liver and kidneys required to complete bioactivation. If these metabolic pathways are compromised, the mechanism is constrained because the required VDR-agonist (Calcitriol) cannot be produced efficiently.

Dosage and Administration Information

How to Use Xarenel (Colecalciferol)

The administration of Xarenel is strictly via the oral route, utilizing dosage forms that include tablets, capsules, and liquid solutions. The use of this medicine is fundamentally structured around two distinct timeframes: an initial, short-term treatment phase, followed by a long-term maintenance regimen. Dosing patterns differ significantly between these phases.

Official Usage Protocols

Context of Use Typical Regimen Frequency Pattern
Deficiency Correction High doses, typically 20,000 IU to 50,000 IU Weekly, for a defined course (e.g., 6–10 weeks)
Maintenance/Prevention Low doses, typically 800 IU to 2,000 IU Daily, or equivalent intermittent dosing

Administration Conditions

Because Colecalciferol is a fat-soluble compound, it must be taken with a meal that contains fat to ensure adequate absorption within the digestive system. This condition is mandatory for proper use. When using the oral liquid solution, the dose must be measured accurately using the calibrated device provided with the product.

If a scheduled dose is missed, instructions advise taking the dose as soon as it is remembered; however, patients are directed not to double the dose to compensate. For patients with severe renal impairment, the use of Colecalciferol is generally not recommended, as alternative vitamin D derivatives are better suited for these individuals.

Recent Clinical Evidence

Recent Clinical Evidence for Xarenel

Recent clinical studies and real-world data continue to support the established efficacy and safety profile of Xarenel (rivaroxaban), a direct Factor Xa inhibitor. This class of medication is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of DVT following orthopedic surgeries such as hip or knee replacement.


Extended Indications and Sub-Populations

Clinical research has focused on the use of Xarenel in diverse patient populations and extended indications. Notable evidence includes:

  • Chronic Kidney Disease (CKD): A prospective observational study (XARENO) demonstrated that Xarenel was associated with a greater net clinical benefit and a reduced risk of kidney failure compared to Vitamin K Antagonists (VKAs) in patients with non-valvular atrial fibrillation and advanced CKD. The results suggested a potential renal protective effect in this vulnerable group.
  • Cancer-Associated Venous Thromboembolism (VTE): Phase 3 trials have explored the use of Xarenel for VTE prevention in high-risk cancer patients. Data from the CASSINI study indicated a nominally significant reduction in VTE events with Xarenel compared to placebo during the period of active treatment. This aligns with prior research supporting its role in the management of cancer-associated thrombosis.

Safety and Long-Term Outcomes

Real-world studies, such as post-marketing surveillance systems (PMSS), consistently corroborate the safety data gathered from landmark randomized controlled trials like ROCKET AF. These analyses confirm that the incidence of major bleeding events in routine clinical practice is generally consistent with that observed in controlled trial settings. Furthermore, analyses conducted by regulatory bodies have affirmed that the primary efficacy and safety results from the pivotal Phase 3 trials remain robust and unaffected by issues related to monitoring devices used in the control arms of older studies. Long-term follow-up in other studies has also supported the sustained clinical activity of Xarenel in combination regimens for reducing the risk of major cardiovascular events in patients with coronary artery disease or peripheral artery disease.

Frequently Asked Questions (FAQ)

Common questions about Xarenel (FAQ)

Q: Are there any long-term health concerns associated with using Xarenel?

Regulatory documents state that Xarenel is typically used for long-term maintenance after an initial treatment phase. Official information notes that serious adverse effects, specifically nephrocalcinosis (calcium deposits in the kidneys) and kidney stone formation, are primarily associated with prolonged exposure to excessively high doses.

Q: Does Xarenel interact with commonly used over-the-counter pain relievers?

According to the official product information, common over-the-counter pain relievers, such as acetaminophen or ibuprofen, are not listed as having a documented or significant interaction with Colecalciferol. The drug interaction sections of official labeling focus on other specific prescription medicines.

Q: What kind of herbal supplements or vitamins might interact with Xarenel?

Official regulatory warnings advise against concurrent use of Xarenel with other high-dose Vitamin D or calcium supplements. This restriction is due to the potential risk of developing hypercalcaemia (excessively high calcium levels in the blood).

Q: Are drug interactions with Xarenel well-documented?

Xarenel contains a long-established substance, Colecalciferol, and its potential interactions with other medicines are documented. Official regulatory prescribing information describes interactions with specific medications, such as certain seizure medicines or diuretics (water pills).

Q: How long does it typically take for the effects of Xarenel to become noticeable?

Studies and official information indicate that although the process of activating the medicine in the body begins quickly, it takes time for this to translate into measurable changes. Measurable increases in blood Vitamin D levels typically take several weeks to months to fully achieve. Therefore, the effects are not usually noticeable immediately after starting treatment.

Q: How long does one dose of Xarenel usually last in the body?

According to pharmacokinetic data found in official regulatory summaries, the key metabolite in your bloodstream, 25-hydroxyvitamin D, has a half-life of about 15 days. This long half-life is what allows the drug to have a sustained, long-term regulatory effect in the body.

Q: Do the effects of Xarenel build up in the system over time?

Yes, the effects of Xarenel are designed to build up over time. Because the substance is fat-soluble and its key metabolite has a long half-life, it remains in the system for an extended period. This is why official use is structured around an initial correction phase followed by a long-term maintenance regimen.

Q: Is Xarenel considered safe for use in older adults (seniors)?

Official labeling does not list general contraindications based solely on age for older adults. In fact, documents note that this population may be at an increased risk of Vitamin D insufficiency. Dosage and monitoring adjustments are generally made based on individual health factors, such as kidney function.

Q: Is Xarenel appropriate for people who have certain liver conditions?

Official documents clarify that the medicine requires the liver to perform the first essential step in converting Colecalciferol into its useful form. This means that if liver function is severely compromised, the body's ability to bioactivate the medicine may be constrained.

Q: Is Xarenel generally suitable for people with a history of heart issues?

The main safety concern noted in regulatory documents involves the risk of high calcium levels (hypercalcaemia). Official information indicates that if hypercalcaemia occurs while taking certain heart medicines (like digitalis glycosides), the risk of serious heart rhythm issues may increase.

Q: What is the research evidence for Xarenel's main approved use?

The medicine is based on Colecalciferol (Vitamin D3). Evidence indicates that its use to correct deficiency and support bone health is supported by decades of scientific literature and clinical experience, reflecting its current status as a widely utilized vitamin analogue.

Q: When was Xarenel first approved by a major regulatory body like the FDA or EMA?

Official documents for the substance, Colecalciferol, often describe it as having a “well-established medicinal use” for over 10 years in many international jurisdictions. This designation reflects the drug's long history of clinical availability and usage.

Q: Are there ongoing clinical trials examining new uses for Xarenel?

Studies and official information indicate that research into Colecalciferol is ongoing. Regulatory bodies track this research, which continues to examine the medicine’s role and potential uses in various health conditions beyond its traditional use for deficiency treatment.

Q: Is Xarenel available in countries outside of the United States?

Yes, official summary documents are published by numerous governmental bodies worldwide, including the EMA, MHRA, and Health Canada. This confirms the medicine's availability and authorized use in multiple international jurisdictions beyond the United States.

Q: Is Xarenel known to be habit-forming or addictive?

According to official prescribing information, Xarenel (Colecalciferol) is not classified as a controlled substance. It is not listed as having abuse potential or being habit-forming in any regulatory documentation.

Q: Is it normal to feel no immediate change when starting treatment with Xarenel?

Yes, this is considered normal. Since the medicine's primary effect is to slowly restore your body's vitamin D blood levels over time, which takes several weeks to months, patients are often advised that they may not feel any immediate difference or sensation after starting the medicine.

Q: Why do some people stop taking Xarenel after a period of time?

Reasons for discontinuation are often related to documented adverse reactions. Official safety profiles list issues such as hypercalcaemia or general gastrointestinal problems like nausea, vomiting, or constipation as possible reactions that may lead to stopping treatment.

Q: Is Xarenel available as a generic medicine?

Yes, the active ingredient in Xarenel, Colecalciferol, is widely available as a generic substance in many different strengths and dosage forms. It is commonly sold both as a dietary supplement and a prescription-only drug.

Q: What is the difference between Xarenel and its generic equivalent?

Regulatory bodies require generic versions to be therapeutically equivalent to the brand-name product. This means the generic must contain the same active ingredient (Colecalciferol), be the same strength, and meet the same strict standards of quality and purity as Xarenel.

Q: Is Xarenel available to buy without a prescription?

The availability depends on the dosage strength. Official guidance states that the substance is commonly available over-the-counter in lower strengths for general supplementation. However, higher-strength loading doses used for severe deficiency correction are typically restricted to prescription-only use.

Q: What is the known half-life of Xarenel?

According to the pharmacokinetic data found in official regulatory documents, the primary metabolite of the drug in your body (25-hydroxyvitamin D) typically has a long half-life of approximately 15 days.

Q: Is there a maximum length of time Xarenel has been studied for continuous use?

The medicine is approved for long-term maintenance and its safety profile is supported by long-term clinical studies and real-world surveillance data. While there is no single maximum duration explicitly defined in the labeling, continuous use is addressed through the safety data gathered over the drug's extended history.

How should Xarenel be stored and disposed of?

The storage and disposal of Xarenel (Colecalciferol) must follow the specific requirements outlined in the official regulatory documents to maintain product stability and safety.

Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store below 25°C or 30°C, typically at room temperature [Source 3.1, 4.3]. Keep from freezing [Source 3.3].
Protection Store in the original container or outer carton to protect from light and moisture [Source 3.1, 3.4].
Child Safety Keep this medicine out of the sight and reach of children [Source 3.1, 3.3].
Stability Oral liquid solutions may have a specified in-use shelf-life (e.g., discard after 60 days) once first opened [Source 1.5].

Disposal Instructions

Unused or expired Xarenel must be disposed of in accordance with local requirements [Source 3.1, 3.4]. The official labeling generally advises not to throw away any medicines via wastewater or household waste [Source 3.1, 3.4], and to use authorized drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Xarenel found in:

A-Z Index: